Cullinan Therapeutics Inc. (CGEM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cullinan Therapeutics Inc...

    NASDAQ: CGEM · Real-Time Price · USD
    5.96
    -0.03 (-0.50%)
    At close: Sep 26, 2025, 3:59 PM
    6.07
    1.85%
    After-hours: Sep 26, 2025, 06:23 PM EDT

    Cullinan Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a 18.94M
    Cost of Revenue
    		 306K 310K 93K 53K
    Gross Profit
    		 -306K -310K -93K 18.89M
    Operating Income
    		 -196.92M -191.09M -132.14M -67.95M
    Interest Income
    		 29.66M 21.63M 6.61M 477K
    Pretax Income
    		 -167.46M -169.22M 151.32M -67.48M
    Net Income
    		 -167.38M -153.16M 111.21M -65.57M
    Selling & General & Admin
    		 53.71M 42.49M 40.19M 29.15M
    Research & Development
    		 142.9M 148.16M 91.95M 57.75M
    Other Expenses
    		 n/a 440K n/a n/a
    Operating Expenses
    		 196.61M 191.09M 132.14M 86.9M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 894K n/a n/a n/a
    Cost & Expenses
    		 196.92M 191.09M 132.14M 86.9M
    Income Tax Expense
    		 117K -14.12M 42.12M n/a
    Shares Outstanding (Basic)
    		 53.77M 41.51M 45.16M 44.29M
    Shares Outstanding (Diluted)
    		 53.77M 41.55M 46.64M 44.29M
    EPS (Basic)
    		 -3.11 -3.69 2.46 -1.48
    EPS (Diluted)
    		 -3.11 -3.69 2.38 -1.48
    EBITDA
    		 -167.15M -190.34M 151.41M -67.9M
    EBIT
    		 -167.46M -190.65M 151.32M -67.95M
    Depreciation & Amortization
    		 306K 310K 93K 53K

    Add to Watchlist